Is Colgate-Palmolive (CL) Still A Bargain On Cash Flow?
π Colgate-Palmolive has returned 35.5% to shareholders over the past five years, demonstrating a strong cash engine supported by steady consumer demand.
π° The company generated approximately $3.85 billion in latest twelve-month free cash flow, providing a solid anchor for valuation models.
π A DCF analysis indicates that projected future cash flows support an intrinsic worth meaningfully above the current share price of US$89.95.
π The bullish narrative attributes potential upside to expansion and premiumization of core oral care lines like Colgate Total and Optic White Pro Series.
β οΈ The bearish narrative warns that normalizing margins while leaving future multiples at GAAP-derived figures could overstate fair value by roughly 45%.
π·οΈ Simply Wall St's community analysis concludes that the bullish view sees more upside in the current price than the cautious, fair value perspective.
- Colgate-Palmolive has delivered a solid run over the past few years with a 35.5% shareholder return over five years.
- The company relies on steady consumer demand and strong cash conversion from household and personal care brands to support consistent reinvestment and payouts.
- A DCF model based on $3.85 billion in latest twelve-month free cash flow suggests the stock is undervalued relative to its future cash generation potential.
- The bullish narrative identifies 9% undervaluation driven by expansion and premiumization of core oral care lines like Colgate Total and Optic White Pro Series.
- A cautious valuation view suggests the stock is roughly fairly valued, noting that double-counting margin adjustments could overstate fair value by roughly 45%.
- The business profile is that of a mature consumer products company where growth is expected to be gradual rather than aggressive step changes.